{"transactions":[{"id":783363,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-05-12T20:30:21.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":56250,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001874384-26-000004","document":"form4-05122026_040517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000187438426000004/form4-05122026_040517.xml","form_type":"4"}},{"id":916736,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-06T21:30:26.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 4, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":75000,"derivative":{"exercise_price":1.96,"expiration_date":"2036-02-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001874384-26-000002","document":"form4-02062026_040219.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000187438426000002/form4-02062026_040219.xml","form_type":"4"}},{"id":960289,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T23:20:12.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":7247,"price":1.38,"value":10000.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split."}],"balance_after":9482,"source":{"system":"sec-edgar","filing":"0001874384-25-000003","document":"form4-12232025_061208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000187438425000003/form4-12232025_061208.xml","form_type":"4"}},{"id":1156707,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":20492,"derivative":{"exercise_price":0.45,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1156706,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 20,492 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1156705,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1156704,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025 in regards to 15,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. The remaining 5,492 warrant shares are unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025 in regards to 15,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. The remaining 5,492 warrant shares are unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":0.1844,"expiration_date":"2025-05-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1156703,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series A Warrants (right to buy)","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025 in regards to 15,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. The remaining 5,492 warrant shares are unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025 in regards to 15,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. The remaining 5,492 warrant shares are unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 20,492 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":5492,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1156702,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-08T00:45:09.000Z","date":"2025-04-30","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":0.1844,"value":2766.0,"ownership":{"direct":true},"balance_after":67071,"source":{"system":"sec-edgar","filing":"0001415889-25-012288","document":"form4-05072025_080505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925012288/form4-05072025_080505.xml","form_type":"4"}},{"id":1279398,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-07T21:15:16.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":343000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":343000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001415889-25-003346","document":"form4-02072025_040211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588925003346/form4-02072025_040211.xml","form_type":"4"}},{"id":1323481,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-23T21:15:12.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":290085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":290085,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":290085},"source":{"system":"sec-edgar","filing":"0001415889-24-030059","document":"form4-12232024_041209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924030059/form4-12232024_041209.xml","form_type":"4"}},{"id":1389664,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series C Warrants (right to buy)","published_at":"2024-10-08T20:15:11.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":25316,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":25316,"derivative":{"exercise_price":0.27,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":25316},"source":{"system":"sec-edgar","filing":"0001415889-24-024869","document":"form4-10082024_041008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924024869/form4-10082024_041008.xml","form_type":"4"}},{"id":1389663,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:11.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":20492,"derivative":{"exercise_price":0.45,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001415889-24-024869","document":"form4-10082024_041008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924024869/form4-10082024_041008.xml","form_type":"4"}},{"id":1389662,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Series A Warrants (right to buy)","published_at":"2024-10-08T20:15:11.000Z","date":"2024-10-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001415889-24-024869","document":"form4-10082024_041008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924024869/form4-10082024_041008.xml","form_type":"4"}},{"id":1389661,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-08T20:15:11.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":25316,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock."}],"balance_after":52071,"source":{"system":"sec-edgar","filing":"0001415889-24-024869","document":"form4-10082024_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924024869/form4-10082024_041008.xml","form_type":"4"}},{"id":1414658,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-05T20:35:11.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a retention award in the form of an option to purchase common stock. Twenty-five percent (25%) of the shares subject to the option shall vest on each of March 4, 2025 and September 4, 2025 and fifty percent (50%) of the shares subject to the option shall vest on March 4, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":250000,"derivative":{"exercise_price":0.47,"expiration_date":"2034-09-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001415889-24-022927","document":"form4-09052024_040907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924022927/form4-09052024_040907.xml","form_type":"4"}},{"id":1654314,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-08T21:46:05.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":189000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":189000,"derivative":{"exercise_price":1.22,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":189000},"source":{"system":"sec-edgar","filing":"0001415889-24-003011","document":"form4-02082024_090253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000141588924003011/form4-02082024_090253.xml","form_type":"4"}},{"id":1710223,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:23:39.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":20492,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001209191-23-058717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123058717/doc4.xml","form_type":"4"}},{"id":1710222,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:23:39.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":20492,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":20492},"source":{"system":"sec-edgar","filing":"0001209191-23-058717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123058717/doc4.xml","form_type":"4"}},{"id":1710221,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-15T13:23:39.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20492,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock."}],"balance_after":26755,"source":{"system":"sec-edgar","filing":"0001209191-23-058717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123058717/doc4.xml","form_type":"4"}},{"id":1795667,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-28T20:43:19.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.03,"value":1030.0,"ownership":{"direct":true},"balance_after":6263,"source":{"system":"sec-edgar","filing":"0001209191-23-047526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123047526/doc4.xml","form_type":"4"}},{"id":1845762,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-06-23T22:28:27.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":87150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":87150,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":87150},"source":{"system":"sec-edgar","filing":"0001209191-23-039509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123039509/doc4.xml","form_type":"4"}},{"id":1918486,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-18T21:04:19.000Z","date":"2023-04-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on April 14, 2024 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":1.22,"expiration_date":"2033-04-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-024698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919123024698/doc4.xml","form_type":"4"}},{"id":2132571,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-25T20:36:38.000Z","date":"2022-10-21","kind":"grant","acquired":true,"shares":59796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in three equal annual installments commencing on October 21, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":59796,"derivative":{"exercise_price":1.48,"expiration_date":"2032-10-21","underlying":"Common Stock","underlying_shares":59796},"source":{"system":"sec-edgar","filing":"0001209191-22-054513","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919122054513/doc4.xml","form_type":"4"}},{"id":2180212,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-18T20:13:20.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":5263,"price":1.9,"value":9999.7,"ownership":{"direct":true},"balance_after":5263,"source":{"system":"sec-edgar","filing":"0001209191-22-046609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919122046609/doc4.xml","form_type":"4"}},{"id":2389918,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-17T21:41:27.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":84500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":84500,"derivative":{"exercise_price":4.28,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":84500},"source":{"system":"sec-edgar","filing":"0001209191-22-010801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919122010801/doc4.xml","form_type":"4"}},{"id":2620667,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":48111,"kind":"person","name":"McCall Patrick","position":1,"cik":"0001874384","reported_name":"McCall Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-03T01:33:29.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the shares subject to the option shall vest in   equal monthly installments commencing on August 29, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":40000,"derivative":{"exercise_price":10,"expiration_date":"2031-07-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-049161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874384/000120919121049161/doc4.xml","form_type":"4"}}]}